Why it's so difficult to produce American-made medical gloves
Efforts to build a fully domestic U.S. supply of medical gloves after COVID-19 have largely stalled, not because factories can’t make them, but because they’re far more expensive than imports from Asia. Commenters highlight structural hurdles such as dependence on foreign nitrile butadiene rubber, higher labor and compliance costs, and procurement systems that revert to the cheapest option once a crisis fades. The exchange broadens into a debate over how much redundancy and onshore capacity a wealthy country should maintain for critical supplies, versus relying on global markets and strategic stockpiles.
Scope of the Problem: Can/Should the US Make Gloves?
- Thread distinguishes between “can’t technically make gloves” and “can’t make them at competitive prices.”
- Article notes only ~1% of gloves used in the US are domestically made, and even those rely on imported rubber.
- Several argue the core issue is cost and buyer preference, not technical incapability.
Reshoring vs Stockpiling
- One camp: US must have domestic capability for critical PPE (gloves as a proxy for broader industrial sovereignty and pandemic resilience).
- Another camp: cheaper and simpler for government to fund large rotating stockpiles, potentially decentralized through hospitals and the Strategic National Stockpile.
- Debate over scale: example cited of ~1.8B gloves/week during COVID; some think multi‑month or 1–2 year buffers are feasible, others see cost and expiry (≈3 years) as constraints.
Raw Materials and Cost Structure
- NBR (nitrile butadiene rubber) is the key input; US has little capacity due to its shale‑heavy petroleum mix, so butadiene comes mostly from Asian/European crackers.
- This structurally advantages Malaysian/SEA production beyond just labor and regulatory costs.
- Some question why government funded projects without accounting for this dependency.
Markets, Efficiency, and Resilience
- Strong debate on whether markets alone optimize for societal resilience.
- Critics: markets optimize for short‑term profit and “number go up,” underinvest in redundancy, and fail in crises (e.g., PPE, toilet paper).
- Defenders: markets have lifted billions from poverty and outperform central planning; failures are exceptions or due to regulation/political distortion.
Policy, Contracts, and Industrial Decline
- Questions about how federal PPE awards are structured, enforcement of deliverables, and whether they created perverse incentives.
- Concern that abandoning domestic production erodes tacit skills, making future re‑industrialization slow and costly.
- Broader worry about Western (especially US) industrial decline versus China’s rise, though some argue specialization and higher labor/safety standards naturally push low‑margin manufacturing abroad.